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Introduction
For more than 150 years of anaesthesia practice it was believed 
that once the anaesthetic has worn off, the brain returns to the 
same state as it was before.1 With emerging evidence in animal 
studies of long-term neurobehavioural deficits after anaesthesia 
exposure, including extensive neuroapoptosis,1 the question 
often comes up from the parents, parents to be and surgical 
colleagues: could the anaesthetic agents cause any long term 
neurological development deficits? What is the evidence? How 
can we prevent this from happening or is this reversible?   
To answer these questions we have to know how the brain 
develops and how anaesthetic drugs influence the brain. 
Understanding that, we may be able to make better choices 
in terms of timing elective surgery in pregnancy as well as 
in the neonate or young child. And if surgery is prudent what 
anaesthetic drug(s) are safer?
Brain development in the human 
The development of the human nervous system consists 
of consecutive steps: neurogenesis starts in the foetus with 
differentiation and neuronal migration followed by establish-
ment of synaptic connections (i.e. synaptogenesis) that continues 
post nataly.2,3 At birth most neurons have migrated to their final 
location in the brain.2 The formation of synapses is dependent 
on electrochemical activity involving the activation of calcium 
channels.3 Neurogenesis and synaptogenesis are activity 
dependent; “neurons that fire together, wire together”2 The 
peak period of myelination occurs during the first two years 
after birth, during which period the brain structures drastically 
change their biochemical composition.4 The brain’s ability to 
learn, remember, forget, recover from injury and reorganise 
is called cerebral plasticity.2 The developing brain has the 
greatest potential for recovery because of an overproduction 
of neurons in the foetus and overproduction of synapses after 
birth.2 Cerebral plasticity not only helps the brain to recover 
from injury, but may also lead to abnormal adaptation and 
therefore abnormal structural changes.2 Adverse experiences 
(e.g., repetitive pain during early brain development) can 
modify neuronal activity patterns and may permanently alter 
the functional wiring of immature neurons.5 This may lead to 
behavioural and emotional problems in childhood, altered pain 
responses, anxiety, depression or suicidal tendencies.2 Apoptosis 
is also a part of normal growth and development,6 and about 
1 % of mammalian brain neurons that are dysfunctional are 
normally pruned in this process to maintain normal functioning 
pathways.7 Brain development is not a uniform process, but 
consists of spurs of increased development followed by periods 
of less brain development occurring in different areas of the 
brain. Neurogenesis and neuronal migration accelerate and 
reach a peak during and after the second trimester of pregnancy.3 
Mechanism of action of anaesthetics on the brain
The majority of anaesthetic agents work by two basic 
mechanisms in the brain: an increase in inhibition via GABA 
receptors (e.g., benzodiazepines, barbiturates, propofol, 
etomidate, isoflurane, enflurane, and halothane),8 and a decrease 
in excitation through NMDA receptors (e.g., ketamine, nitrous 
oxide (N2O), and xenon).9,10 The exception to these mechanisms 
is dexmedetomidine. The drug is a potent α-2 adrenoceptor 
agonist that has eight times higher affinity for the α-2 adreno-
ceptor than clonidine. Dexmedetomidine has sedative, analgesic 
and anxiolytic properties.11 Recent findings indicate that drugs 
that act by either stimulation of GABA receptors or inhibition 
of NMDA receptors, induce widespread neuronal apoptosis in 
immature rat brain when administered during synaptogenesis.12 
Apoptosis is increased if neurons are exposed to a combination 
of GABA agonists and NMDA antagonists.7 Neuronal exposure 
to anaesthetics during a critical neurodevelopmental period 
triggers an unknown chain of events causing translocation of 
BCL2-associated X protein (Bax) to mitochondria, followed by 
mitochondrial membrane disruption and permeability, resulting 
in leakage of cytochrome c into the cytosol.7
Southern African Journal of Anaesthesia and Analgesia 2014; 20(4):167-169
Open Access article distributed under the terms of the 
Creative Commons License [CC BY-NC-ND 4.0] 
http://creativecommons.org/licenses/by-nc-nd/4.0
Anaesthesia and the developing brain
Prozesky J, Assistant Professor, Department of Paediatric Anaesthesia, Penn State Hershey Medical Center, United States  
Author e-mail: jprozesky@hmc.psu.edu
Abstract: 
Increasing concern about the effect of anaesthesia on the infant and young child is raised by health care practitioners as well as the 
public immature neurons exposed to anaesthesia may lead to apoptosis and long-term neurobehavioural deficits in animals.. The 
majority of anaesthetic agents work by influencing GABA or NMDA receptors and may induce animal neuro apoptosis. The search for 
neuroprotective strategies to reverse or counter act the effect of anaesthesia, so far, has not been very successful. Dexmedetomidine 
is an α-2 adrenoreceptor and may have neuroprotective effects. The available human studies have failed to prove any long-term 
neurobehavioural deficiencies caused by anaesthetic exposure. Large international prospective studies are currently on the way 
that may change the practice of paediatric and obstetric anaesthesiologists in the future.
South Afr J Anaesth Analg
ISSN 1608-4356     EISSN 1727-9835 
© 2014 SASA
Review
13-14 September 2014, The Forum, BryanstonThe Anaesthetic Foundation Edition 11
Southern African Journal of Anaesthesia and Analgesia 2014; 20(4):167-169168
The evidence
Animal studies
In analysing the literature, it is important to keep a few details 
about the animal model in consideration. The lifespan of the 
rodent is about three years, and synaptogenesis occurs mainly 
after birth.3 Therefore, the neuron lifespan of the rodent is a 
maximum of 3 years in comparison with the human neuron 
lifespan that may be over 100 years.6 It is important to recognise 
that the anaesthetic exposure of a rat is equivalent to a much 
longer exposure in humans. An anaesthetic exposure of six hours 
in the pregnant rat, extrapolated to the human, may be over 48 
hours of anaesthesia exposure in the pregnant human, and thus 
may only be relevant in intensive care sedation settings.3 
Evidence in the animal models indicates long-term neuro-
development deficiencies after anaesthesia exposure. The 
infant rat exposed to commonly used anaesthetics (midazolam, 
N2O  and isoflurane) in clinically relevant dosages, caused 
widespread apoptotic neurodegeneration in the brain as well 
as persistent memory/learning impairments.13 These data have 
been reproduced in other species and had similar results.6 A 
study in monkeys reported persistent neurocognitive deficits 
several years after 24 hrs of exposure to ketamine.6 The volatile 
anaesthetics, isoflurane and sevoflurane and intravenous agents, 
propofol, ketamine, midazolam, diazepam and thiopentone 
have all induced neuronal apoptosis in some situations in 
rodents.14 A hypothesis for the mechanism of neuronal injury 
is based on the synaptic neurotransmission suppression that 
causes neuronal death; if this proves to be true, anaesthetics may 
induce apoptosis irrespective of the agent used.14 
Human studies
There are no prospective studies, and may never be, evaluating 
neurocognitive function in children after neonatal exposure to 
anaesthetics. Several retrospective studies have been published 
since 2007. A study published by the Mayo Clinic in 2009, 
that assessed the impact of obstetric anaesthesia on learning 
disabilities in children younger than five years, concluded that 
there was no evidence of harm following Caesarean and vaginal 
delivery.15 A feasibility pilot study, published by a group from The 
Netherlands in the same year, assessed the neurobehavioural 
development after a single anaesthesia exposure before age 6 
years, by using a questionnaire at age 1 – 14 years. The authors 
concluded that, with the size of the study, there is no “indis-
putable evidence” against the use of anaesthesia in the young.16 
The same year, another study came out about the association 
between anaesthetic exposure before age 4 years and the 
development of reading, written language and math learning 
disabilities. The authors concluded that multiple exposures to 
anaesthesia may contribute to learning disabilities, but added 
that perhaps the need for anaesthesia maybe a marker for other 
unidentified factors contributing to learning disabilities.17 A study 
that examined twins, with one child exposed to anaesthesia and 
the other not, concluded that there was no evidence for a causal 
relationship between anaesthesia administration and learning-
related outcomes. They concluded that early anaesthesia is a 
marker of an individual’s vulnerability for later learning problems, 
regardless of their exposure to anaesthesia.18
Surgery during pregnancy 
Historically, the 2nd trimester was considered the safest period 
during pregnancy for surgery and anaesthesia.3 The focus has 
been on the first trimester, due to concerns for teratogenicity 
during embryogenesis, and the 3rd trimester, due to concerns 
of premature labour.3  However, recently, the safety of surgery 
and anaesthesia during the 2nd trimester has been questioned 
because of foetal neuro-development during this period.3 
The underlying mechanism of the potential, intrauterine anae-
sthetic drug-induced, neurological changes during pregnancy 
is not fully understood.3 It seems that since GABA is a trophic 
factor for the developing brain, use of GABA stimulating 
agents during critical brain development periods can lead 
to neural connectivity injury.3 Reduced synaptic activity and 
neuroapoptosis in the developing brain can be triggered even by 
a short exposure to commonly used anaesthetics like propofol, 
ketamine, nitrous oxide, isoflurane, sevoflurane, barbiturates 
and benzodiazepines.14 Combinations of anaesthetic drugs can 
increase the severity of neuroapoptosis.14 
However, it is very difficult to translate animal studies to 
humans. In contrast with the rodent, where rapid brain growth 
(synaptogenesis) takes place after birth, in the humans, the 
process starts in mid gestation and continues for a number of 
years after birth.3 
Surgery in the child
Recent clinical studies suggest that major disability is unlikely 
with brief exposure in an older child.14 It is known that anae-
sthesia induced neurotoxicity is a real phenomenon in the 
young rodent.14 Infants are rarely exposed to anaesthesia in 
isolation.14 There are many other factors that could lead to 
neurotoxicity; e.g., untreated pain induces significant long-
term harmful consequenses.14 In addition, hypercarbia has 
been associated with neuronal apoptosis in neonatal animals.14 
There are many confounding factors that influence the results 
of human studies. Children who require more interventions/
anaesthetics usually have significant chronic illnesses  that 
may, per se, contribute to learning disabilities.14 Another factor 
is that the majority of the studies did not comment on subtle 
neurobehavioural deficiencies. Environmental influences, e.g., 
lag in psychosocial stimulation, resulted in lower intelligence 
quotients and memory scores and more behavioural difficulties 
in children.2
Neuroprotective strategies
If all anaesthetic agents may be detrimental to neurobehavioural 
development in the unborn or young, are there any strategies/
medications to reverse or counteract the effects?
Erythropoietin, antidepressants, lithium, etc., are all modalities 
that may enhance recovery after cerebral injury.1, 2 Melatonin is 
worth mentioning. Melatonin was found to reduce anaesthesia-
induced neuronal apoptosis in rats in a dose-dependent 
way. It was previously shown that melatonin counteracts the 
mitochondrial biochemical changes by anaesthetics that lead 
to apoptosis. Melatonin causes an up-regulation of the anti-
apoptotic protein and a decrease in anaesthesia-induced 
cytochrome c release into the cytoplasm. Also melatonin causes 
a decrease in anaesthesia-induced activation of caspase-3, an 
important step in the activation of DNAses and the formation 
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of the apoptotic bodies.19 Another nonspecific neuroprotective 
effect of melatonin may be the ability to decrease the require-
ment of anaesthesia by inducing sleep and attenuating analgesia.1 
Hypothermia demonstrated neuroprotective effects in several 
neonatal studies with hypoxic-ischaemic encephalopathy 
and improved neurologic outcome.2 Hypothermia has its own 
harmful effects on newborns and this is well described in the 
literature (e.g., impairment of transition from intrauterine to 
extrauterine circulatory pathways by increasing pulmonary 
vascular resistance).20
Because dexmedetomidine is neither a GABAergic nor 
NMDA antagonist, it has been hypothesised that it is free of 
developmental anaesthetic toxicity. Dexmedetomidine improves 
the neurocognitive deficit induced by a subanaesthetic dose of 
isoflurane, by reducing neuronal apoptosis in a dose-dependent 
way. This was reversed by blocking the α-2 adrenoceptor, 
indicating that the protective effect is mediated by this 
receptor.1 Unfortunately, at present, there is no convincing data 
to propagate the use of any of these agents in the human, with 
or after anaesthesia exposure.1,6
The future
With so many questions and so few answers, several international 
research groups are currently conducting research to help us 
better understand this very important concern:
•	 GAS study: international, multi-site, randomised controlled 
study that is investigating if the long-term effects of spinal- 
and general anaesthesia result in the same neurodevelopment 
outcomes.
•	 PANDA study (Pediatric Anaesthesia Neuro Development 
Assessment Study): multicentre USA group; their focus is 
to compare the neurodevelopment of children exposed to 
anaesthesia and those not exposed to anaesthesia. 
•	 Oregan University group: Ansgar Brambrink, with a multi-
disciplinary group, is investigating the long-term functional 
and morphologic consequences of single vs. triple anaesthesia 
exposure of infant non-human primates. 
•	 NCTR (National Center for Toxicological Research): a group 
in the USA, is conducting non-clinical studies, in rodents 
and nonhuman primates, to assess mechanisms, long-term 
deficits and strategies to prevent/decrease neurotoxicity with 
clinically-relevant anaesthesia. 
•	 MASK study: Mayo Clinic with the NCTR, the study compares 
performance of children with no anaesthetic exposure to 
those with single or multiple exposures.
SmartTots (Strategies for Mitigating Anaesthesia-Related 
neuroToxicity in Tots) is a collaborative effort between the US 
Food and Drug Administration (FDA) and the International 
Anaesthesia Research Society (IARS) to coordinate and fund 
some of the above research programs.
Conclusion
Research in animal studies indicates that anaesthetic exposure 
of the immature brain causes long-term anatomical and neu-
robehavioural deficits. The limited data available from prenatal 
animal studies indicate that the brain is vulnerable to the mater-
nal exposure of anaesthesia, especially from the second trimes-
ter onwards. All anaesthetic agents may be harmful and have an 
additive effect. No agent or modality was proved to counteract 
or neutralise the anaesthetic effect on the brain. Human stud-
ies are limited and are lacking evidence of detrimental effect on 
the neonatal and foetal brain. Currently, there is not sufficient 
evidence to warrant a change in paediatric anaesthesia practice, 
postponing necessary procedures, or withholding necessary 
analgesics, sedatives or anaesthetics from pregnant as well as 
neonatal and young patients. This is unethical and may lead to 
significant harm. Multicentre, international studies are under-
way and hopefully will delineate the risk of anaesthesia exposure 
in the foetus and newborn. 
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